Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07204691) titled 'A Study to Evaluate the Safety and Performance of Dr Korman Laboratories' Hyaluronic Acid Filler 20 mg/mL With Lidocaine for Lip Augmentation' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Dr. Korman Laboratories Ltd.
Condition:
Lip Augmentation
Intervention:
Device: DKL crosslinked sodium hyaluronate 20 mg/mL + Lidocaine 0.3% dermal filler...
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 24, 2025
Target Sample Size: 75
Countr...